An update on chemical eye burns.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
09 2019
Historique:
received: 08 01 2018
accepted: 02 04 2019
revised: 06 02 2019
pubmed: 16 5 2019
medline: 7 8 2020
entrez: 16 5 2019
Statut: ppublish

Résumé

Ocular chemical injuries vary in severity, with the more severe end of the spectrum having profound visual consequences and medicolegal implications. Grading of ocular injuries is critical for determining acute treatment and visual prognosis. Poor immediate management results in more challenging treatment of acute disease. Similarly, poorly controlled acute disease results in more treatment-resistant chronic ocular disease. Despite several decades of research and public health initiatives, simple and effective interventions such as wearing protective eyewear and immediate irrigation of eyes remain as key challenges. Education and prevention are therefore important public health messages. Hurdles in the acute management of disease include poor evidence-base for commonly used treatments (e.g. based on experimental animal studies), reduced treatment adherence rates and high clinic non-attendance rates. The evolution of treatment strategies, particularly limbal stem cell transplantation, has revolutionised the visual and cosmetic outcomes in chronic phases of disease. It is therefore increasingly important to consider tertiary referral for patients with limbal stem cell failure or vision-limiting corneal scarring.

Identifiants

pubmed: 31086244
doi: 10.1038/s41433-019-0456-5
pii: 10.1038/s41433-019-0456-5
pmc: PMC7002428
doi:

Substances chimiques

Acids 0
Alkalies 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1362-1377

Références

Surv Ophthalmol. 1997 Jan-Feb;41(4):275-313
pubmed: 9104767
PLoS One. 2013 Oct 30;8(10):e78441
pubmed: 24205233
Eye Ear Nose Throat Mon. 1964 Jan;43:57-61
pubmed: 14116244
Br J Ophthalmol. 1987 Nov;71(11):854-7
pubmed: 3689738
J Fr Ophtalmol. 1999 Dec;22(10):1047-53
pubmed: 10617842
Cornea. 1991 Mar;10(2):100-4
pubmed: 2019118
Cornea. 2000 May;19(3):274-7
pubmed: 10832682
Am J Ind Med. 2005 Jul;48(1):57-62
pubmed: 15940717
Graefes Arch Clin Exp Ophthalmol. 1993 May;231(5):308-12
pubmed: 8319922
Clin Ophthalmol. 2018 Oct 17;12:2103-2106
pubmed: 30410305
Stem Cells. 2017 Oct;35(10):2105-2114
pubmed: 28748596
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD006527
pubmed: 19821372
Acta Ophthalmol Scand. 2002 Feb;80(1):4-10
pubmed: 11906296
Semin Ophthalmol. 2018;33(1):134-141
pubmed: 29172876
Surv Ophthalmol. 2018 Mar - Apr;63(2):214-235
pubmed: 28935121
Ocul Surf. 2017 Jan;15(1):48-64
pubmed: 27650263
Occup Environ Med. 2009 Aug;66(8):517-22
pubmed: 19286683
Am J Ophthalmol. 2012 Sep;154(3):481-485.e1
pubmed: 22633350
Aust J Ophthalmol. 1983 Nov;11(4):281-6
pubmed: 6421269
Am J Ophthalmol. 2000 Nov;130(5):688
pubmed: 11078862
J AAPOS. 2018 Dec;22(6):426-428
pubmed: 30342182
Indian J Ophthalmol. 2019 Jan;67(1):32-36
pubmed: 30574887
Invest Ophthalmol Vis Sci. 1980 Dec;19(12):1526-9
pubmed: 7440108
Ocul Surf. 2017 Oct;15(4):789-794
pubmed: 28827194
Prog Retin Eye Res. 2000 Jan;19(1):113-29
pubmed: 10614683
Invest Ophthalmol Vis Sci. 1988 Jul;29(7):1110-5
pubmed: 3417403
Arch Ophthalmol. 1978 Nov;96(11):2117-20
pubmed: 214063
Cornea. 2017 Sep;36(9):1031-1035
pubmed: 28644241
Am J Pathol. 2017 Jun;187(6):1327-1342
pubmed: 28412300
Ophthalmology. 1980 Aug;87(8):753-8
pubmed: 7443202
Cornea. 2015 Dec;34(12):1527-33
pubmed: 26488629
Regen Med. 2016 Jun;11(4):407-20
pubmed: 27091398
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009379
pubmed: 22972141
Burns. 2005 Mar;31(2):205-11
pubmed: 15683694
Trans Ophthalmol Soc U K. 1965;85:631-53
pubmed: 5227208
Trans Am Ophthalmol Soc. 1990;88:649-84
pubmed: 2095035
Am J Ophthalmol. 1968 Oct;66(4):654-7
pubmed: 5729582
Ophthalmology. 2013 Jun;120(6):1195-200
pubmed: 23499061
Cornea. 2016 Oct;35(10):e32-5
pubmed: 27467040
Ophthalmologica. 2006;220(4):225-8
pubmed: 16785752
Pediatr Emerg Care. 2011 Feb;27(2):151-6
pubmed: 21293228
Am J Ophthalmol. 2007 Jul;144(1):86-92
pubmed: 17493572
Ocul Surf. 2018 Jul;16(3):272-281
pubmed: 29597010
Ophthalmology. 2000 Oct;107(10):1829-35
pubmed: 11013181
Histol Histopathol. 2014 Apr;29(4):457-78
pubmed: 24105332
Ophthalmol Ther. 2019 Jun;8(2):251-259
pubmed: 30868417
Eye Contact Lens. 2013 Sep;39(5):341-7
pubmed: 23945524
BMJ. 2010 Mar 02;340:c1186
pubmed: 20197325
Arch Ophthal. 1946 Feb;35:98-108
pubmed: 21018056
Burns. 2018 Jun;44(4):1021-1022
pubmed: 29576343
JAMA Ophthalmol. 2016 Oct 1;134(10):1119-1124
pubmed: 27490908
Ann Afr Med. 2007 Mar;6(1):7-11
pubmed: 18240484
Ophthalmology. 1983 Oct;90(10):1246-53
pubmed: 6657201
Arch Ophthal. 1946 Aug;36:189-214
pubmed: 20997671
Occup Health Saf. 1989 Apr;58(4):33-6
pubmed: 2733955
Br J Ophthalmol. 2016 Jan;100(1):22-7
pubmed: 26178904
Cornea. 2015 May;34(5):592-600
pubmed: 25789694
Ophthalmology. 2004 Jan;111(1):70-4
pubmed: 14711716
Br J Ophthalmol. 1990 Sep;74(9):514-8
pubmed: 2393641
Arch Ophthalmol. 1987 Feb;105(2):268-71
pubmed: 3813962
Am J Ophthalmol. 1975 Mar;79(3):414-9
pubmed: 235843
Invest Ophthalmol Vis Sci. 2011 Feb 25;52(2):1087-92
pubmed: 20538982
Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):845-54
pubmed: 16365735
Curr Eye Res. 2012 Dec;37(12):1084-90
pubmed: 23025713
Br J Ophthalmol. 1997 Sep;81(9):732-4
pubmed: 9422923
Cell Tissue Bank. 2016 Sep;17(3):399-406
pubmed: 27072557
Cornea. 2018 Aug;37(8):993-999
pubmed: 29781925
Ophthalmic Res. 1984;16(4):185-9
pubmed: 6472797
Eye (Lond). 2017 Mar;31(3):372-378
pubmed: 27768117
Br J Ophthalmol. 2011 Feb;95(2):194-8
pubmed: 20805137
Am J Ophthalmol. 2019 Mar;199:209-215
pubmed: 30419194
Br J Ophthalmol. 2017 Feb;101(2):103-107
pubmed: 27150827
Ophthalmology. 1980 Oct;87(10):1050-7
pubmed: 7243199
Ocul Surf. 2012 Jan;10(1):15-25
pubmed: 22330056
Ophthalmologe. 2001 Dec;98(12):1149-56
pubmed: 11799897
Cornea. 2018 Oct;37(10):1249-1254
pubmed: 29975208
Cornea. 1999 Mar;18(2):164-71
pubmed: 10090361
Invest Ophthalmol. 1976 Dec;15(12):986-93
pubmed: 992963
Br J Ophthalmol. 2018 Aug;102(8):1114-1121
pubmed: 29141906
Burns. 2004 Sep;30(6):569-72
pubmed: 15302423
Ophthalmology. 2016 May;123(5):1000-10
pubmed: 26896125
Int Arch Occup Environ Health. 1995;67(4):281-4
pubmed: 7591189
Graefes Arch Clin Exp Ophthalmol. 2002 Apr;240(4):308-13
pubmed: 11981646
Am J Ophthalmol. 2016 Aug;168:157-163
pubmed: 27210276
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):96-105
pubmed: 28114570
J Cataract Refract Surg. 2016 Sep;42(9):1368-1379
pubmed: 27697257
Klin Monbl Augenheilkd. 1994 Aug;205(2):86-92
pubmed: 7967411
Am J Ophthalmol. 2017 Dec;184:97-107
pubmed: 29032107
Cornea. 2017 Aug;36(8):1014-1017
pubmed: 28679131
BMJ. 1995 Apr 8;310(6984):943
pubmed: 7719217
Ophthalmology. 2010 Dec;117(12):2268-72
pubmed: 20591491
Br J Ophthalmol. 2012 Dec;96(12):1504-9
pubmed: 22976585
Ophthalmology. 2005 Nov;112(11):1963-9
pubmed: 16198422
Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1507-13
pubmed: 17492301
Cornea. 2006 Jun;25(5):530-2
pubmed: 16783140
Acta Ophthalmol. 2014 Sep;92(6):e447-53
pubmed: 24835597
Ophthalmology. 2014 Jan;121(1):377-380
pubmed: 23948464
J Biomed Opt. 2007 Jul-Aug;12(4):041203
pubmed: 17867792
Eye (Lond). 1994;8 ( Pt 4):384-8
pubmed: 7821456
Cornea. 2019 Jan;38(1):8-12
pubmed: 30199398
Cornea. 2017 Sep;36(9):1106-1115
pubmed: 28704317
Br J Ophthalmol. 2011 Feb;95(2):199-204
pubmed: 20675729
Br J Ophthalmol. 2018 Dec;102(12):1640-1645
pubmed: 29453224
Br J Ophthalmol. 2009 Sep;93(9):1177-80
pubmed: 19416936
Burns. 1993 Feb;19(1):67-9
pubmed: 8435120
Cornea. 2011 Dec;30(12):1322-7
pubmed: 22001817
Br J Ophthalmol. 2001 Nov;85(11):1379-83
pubmed: 11673310

Auteurs

Mukhtar Bizrah (M)

Imperial College Healthcare NHS Trust, Western Eye Hospital, 153-173 Marylebone Road, London, NW1 5QH, UK. mbizrah@gmail.com.

Ammar Yusuf (A)

UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK.

Sajjad Ahmad (S)

Moorfields Eye Hospital NHS Foundation Trust, 162 City Road, London, EC1V 2PD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH